Vaccine investment is a no-brainer — so why aren’t we doing it?

Not only is the cost-benefit ratio unbeatable, but not to undertake this spending is to court disaster
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×